ARCHIVES

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

November 27, 1987

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

Hammer Signs $2.5 Mil. Check To NCI Fro Stop Cancer Campaign

February 2, 1990

Surgery Without Radiation Found Inadequate for DCIS

December 26, 2003

Senate Committee Adds $100 Million for Cancer, Earmarks Extra Positions for NCI, Backs New Construction

September 19, 1975